Trials Sponsors Conditions Drugs Pricing

Conditions

Diabetic Foot Ulcer

Keywords

platelet rich gelBMMSCsdiabetic foot ulcer

Outcome Measures

Primary Outcomes (2)

Amputation rate
Amputation rate up to 6 months
up to 6 months
hospital stay
hospital stay
up to 6 months

Secondary Outcomes (2)

Wound healing time
up to 6 months
Transcutaneous oxygen partial pressure
Transcutaneous oxygen partial pressure up to 6 months

Study Arms (3)

Traditional treatment

PLACEBO COMPARATOR

Traditional treatment such as insulin,antidiabetes,dressing

Biological: PRG combined with BMMSCs transplantation

PRG combined with BMMSCs transplantation

EXPERIMENTAL

Traditional treatment such as insulin,antidiabetes,dressing and Autologous PRG combined with BMMSCs

Biological: PRG combined with BMMSCs transplantation

PRG treatment

NO INTERVENTION

Traditional treatment such as insulin,antidiabetes,dressing and Autologous PRG

Interventions

PRG combined with BMMSCs transplantationBiological

PRG combined with BMMSCs transplantation

Also known as: PRG

PRG combined with BMMSCs transplantationTraditional treatment

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Diabetic foot according to The Wagner is 2-3 graded;

You may not qualify if:

Sponsors & Collaborators

Third Military Medical University
Otherlead

Study Sites (2)

Southwest Hospital of the Third Military Medical University

Chongqing, Chongqing Municipality, +86, China

RECRUITING

wu qinan, doctorCONTACT13452867542 wqn11@126.com

Endocrine Department, the First Affiliated Hospital of the Third Military Medical University

Chongqing, Chongqing Municipality, 400038, China

RECRUITING

qinan wu, masterCONTACT02368765217 ext. 86

MeSH Terms

Conditions

Diabetic Foot

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Design

Study Type: interventional
Phase: early phase 1
Allocation: NON RANDOMIZED
Masking: SINGLE
Who Masked: OUTCOMES ASSESSOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Doctor

Study Record Dates

First Submitted

August 9, 2017

First Posted

August 14, 2017

Study Start

August 30, 2017

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Study Arms (3)

Traditional treatment

PRG combined with BMMSCs transplantation

PRG treatment

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Study Arms (3)

Traditional treatment

PRG combined with BMMSCs transplantation

PRG treatment

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Data Sharing

Source record

Locations